AKANNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
AKANDA CORP.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 9, 2026
$1.12−0.08 (-6.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$10.33 (−90.22%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
AKANDA CORP. grew revenue 97.5% to $836.66K over fiscal 2024. Free cash flow was -$6.08M.
Revenue
$836.66K
+97.5% vs. a year earlier
Operating income
-$4.38M
FY2024
Free cash flow
-$6.08M
FY2024
EPS, diluted
-$3.93
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $836.66K
- EPS, diluted
- -$3.93
- Free cash flow
- -$6.08M
Seven years at a glance
Fiscal years 2018 to 2024, USD
Revenue
$836.66K+97.5% YoY
Gross profit
$208.38K+251.2% YoY
Operating income
-$4.38M
EPS, diluted
-$3.93
Free cash flow
-$6.08M
Reported period